Browse Category

NASDAQ:ACLX News 9 December 2025

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Published: December 9, 2025 Arcellx, Inc. (NASDAQ: ACLX) has jumped back onto Wall Street’s radar after releasing highly positive Phase 2 data for its multiple myeloma cell therapy anitocabtagene autoleucel (“anito-cel”) at the American Society of Hematology (ASH) 2025 meeting. The new data have driven a sharp move in the stock, a flurry of analyst updates, and renewed debate about…

Stock Market Today

  • Charles Schwab Corp (SCHW) March 27 Options Now Trading with Attractive YieldBoost Opportunities
    February 5, 2026, 1:37 PM EST. Charles Schwab Corp (SCHW) options expiring March 27 are now available. A notable put option at a $95 strike offers a 17-cent premium, allowing investors to buy shares at an effective $94.83 cost basis, about 7% below the current $101.78 market price. There's a 78% chance this put expires worthless, yielding a 0.18% return (1.31% annualized) via Stock Options Channel's YieldBoost metric. On the call side, the $112 strike call contracts offer a 33-cent premium. Selling covered calls at this strike could generate a potential 10.37% return if shares are called away. The $112 strike is roughly 10% above current prices, making it out-of-the-money, so calls may expire worthless with investors retaining shares plus premium. Both strategies hinge on careful analysis of Schwab's price history and fundamentals.
Go toTop